Brill, G.; Manor, I.; Bril Paroz, R.; Ashkenazi, S.; Cohen, S.; Golan-Cohen, A.; Green, I.; Israel, A.; Vinker, S.; Weizman, A.;
et al. The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study. Children 2022, 9, 1844.
https://doi.org/10.3390/children9121844
AMA Style
Brill G, Manor I, Bril Paroz R, Ashkenazi S, Cohen S, Golan-Cohen A, Green I, Israel A, Vinker S, Weizman A,
et al. The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study. Children. 2022; 9(12):1844.
https://doi.org/10.3390/children9121844
Chicago/Turabian Style
Brill, Gherta, Iris Manor, Roberta Bril Paroz, Shai Ashkenazi, Shira Cohen, Avivit Golan-Cohen, Ilan Green, Ariel Israel, Shlomo Vinker, Abraham Weizman,
and et al. 2022. "The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study" Children 9, no. 12: 1844.
https://doi.org/10.3390/children9121844
APA Style
Brill, G., Manor, I., Bril Paroz, R., Ashkenazi, S., Cohen, S., Golan-Cohen, A., Green, I., Israel, A., Vinker, S., Weizman, A., & Merzon, E.
(2022). The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study. Children, 9(12), 1844.
https://doi.org/10.3390/children9121844
